My Video Playlist »
Empty Playlist
|
|
|
This will be a day in the life interview for Merck & Company. For their next several jobcasts we’ll be profiling various mili...
This will be a day in the life interview for Merck & Company. For their next several jobcasts we’ll be profiling various military veterans about their experience as they...
0
|
This will be a day in the life interview for Merck & Company. For their next several jobcasts we’ll be profiling various mili... |
|
|
|
|
|
|
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, sha...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, shares her reaction. (CNBC) Abbott Laboratories -...
|
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, sha... |
|
|
|
|
|
|
Retail stocks will also be active, with many companies offering March sales reports before the bell.
Retail stocks will also be active, with many companies offering March sales reports before the bell.
0
|
Retail stocks will also be active, with many companies offering March sales reports before the bell. |
|
|
|
|
|
|
For their next several jobcasts we’ll be profiling various Merck military veterans about their experience as they transition ...
For their next several jobcasts we’ll be profiling various Merck military veterans about their experience as they transition from military to civilian life while working for one...
0
|
For their next several jobcasts we’ll be profiling various Merck military veterans about their experience as they transition ... |
|
|
|
|
|
|
PTG Srudios is pleased to announce the selection of Merck for its innovative, educational television series, Health Forum. Th...
PTG Srudios is pleased to announce the selection of Merck for its innovative, educational television series, Health Forum. The company will feature an educational segment on the...
0
|
PTG Srudios is pleased to announce the selection of Merck for its innovative, educational television series, Health Forum. Th... |
|
|
|
|
|
|
Ouverture Wall Street 03/02/11. Malgré de bonnes données macroéconomiques aux Etats-Unis, les investisseurs restent toujours ...
Ouverture Wall Street 03/02/11. Malgré de bonnes données macroéconomiques aux Etats-Unis, les investisseurs restent toujours prudents face à la nouvelle escalade des violences...
1
|
Ouverture Wall Street 03/02/11. Malgré de bonnes données macroéconomiques aux Etats-Unis, les investisseurs restent toujours ... |
|
|
|
|
|
|
GARDASIL , Merck's Cervical Cancer Vaccine, Basic B-roll Package
GARDASIL , Merck's Cervical Cancer Vaccine, Basic B-roll Package
1
|
GARDASIL , Merck's Cervical Cancer Vaccine, Basic B-roll Package |
|
|
|
|
|
|
Merck backing off
Merck backing off
0
|
Merck backing off |
|
|
|
|
|
|
This jobcast will feature biotechnician careers with Merck & Company. Merck is a global research-driven pharmaceutical compan...
This jobcast will feature biotechnician careers with Merck & Company. Merck is a global research-driven pharmaceutical company dedicated to putting patients first. Established in...
0
|
This jobcast will feature biotechnician careers with Merck & Company. Merck is a global research-driven pharmaceutical compan... |
|
|
|
|
|
|
Merck and Schering-Plough's $41 billion deal does little to boost investor sentiment.
Merck and Schering-Plough's $41 billion deal does little to boost investor sentiment.
|
Merck and Schering-Plough's $41 billion deal does little to boost investor sentiment. |
|
|
|
|
|
